Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
naptumomab estafenatox oncotrophoblast glycoprotein 5t4 NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA phase 2/3 antibody
naptumomab estafenatox oncotrophoblast glycoprotein 5t4 NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA phase 2/3 unknown
naptumomab estafenatox oncotrophoblast glycoprotein 5t4 NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 15.91 phase 2/3 unknown
click here to return to the previous page